AstraZeneca Pharma India Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on AstraZeneca Pharma India Ltd. from all sources in a single place.

Load latest

AstraZeneca Pharma India Ltd.

09 Dec 2021

9027.50

2.49%

AstraZeneca in touch with Indian authorities for approval to Covid drug

Business Standard

The company said it has initiated engagements with Indian health authorities regarding its Covid prevention drug for people with weakened immune system

Number of FII/FPI investors increased from 164 to 181 in Jun 2025 qtr.

After US nod, AstraZeneca moves Indian authorities over long-acting antibody mix

Business Line | 09 Dec 2021 4 more

AstraZeneca Pharma India Ltd.

09 Dec 2021

9027.50

2.49%

Ipca, AstraZeneca, Torrent, Sun Pharma outshine Indian pharma market in Nov

livemint

Growth in volume terms, however, remained flat year-on-year during November, but it was the 5.4% rise in prices and new product launches that helped drive IPM growth

AstraZeneca Pharma India Ltd. is trading above all available SMAs

AstraZeneca Pharma India Ltd.

08 Dec 2021

9027.50

2.49%

Company Update

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

We are enclosing herewith Certificate dated December 2, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

pdf

AstraZeneca Pharma India Ltd.

08 Dec 2021

9027.50

2.49%

Corp. Note

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agents of the Company, Integrated Registry Management Services Private Limited have informed the Company on the below request for loss of share certificate from the claimant

pdf

AstraZeneca Pharma India Ltd.

06 Dec 2021

9027.50

2.49%

Next pandemic could be more lethal than Covid: AstraZeneca vaccine maker

Business Standard

Future pandemics could be even more lethal than Covid so the lessons learned from the pandemic must not be squandered, one of the creators of the Oxford-AstraZeneca vaccine said.

AstraZeneca Pharma India Ltd. is trading above all available SMAs

AstraZeneca Pharma India Ltd.

04 Dec 2021

9027.50

2.49%

AstraZeneca studies listing of new vaccines division

livemint

AstraZeneca Plc has been studying options including a potential listing of its newly-created vaccines division as it seeks ways to boost returns for investors, people with knowledge of the matter said.

AstraZeneca Pharma India Ltd.'s price crossed above 50Day SMA today

AstraZeneca blocks Advent's $7.6-bn buyout of Swedish Orphan Biovitrum

Business Standard | 04 Dec 2021

AstraZeneca Pharma India Ltd.

03 Dec 2021

9027.50

2.49%

Booster dose of six COVID vaccines safe, increases immunity: Lancet study

Moneycontrol

The vaccines studied were AstraZeneca, Pfizer-BioNTech, Novavax, Janssen, Moderna, Valneva, and Curevac.

Number of MF schemes increased from 53 to 60 in Jun 2025 qtr.

Booster dose of six Covid vaccines safe, increases immunity: Lancet study

Business Standard | 03 Dec 2021 1 more

AstraZeneca Pharma India Ltd.

29 Nov 2021

9027.50

2.49%

Company Update

AstraZeneca Pharma India Ltd - 506820 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

We are enclosing herewith Certificate dated November 3, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

pdf

AstraZeneca Pharma India Ltd.

29 Nov 2021

9027.50

2.49%

Result

AstraZeneca Pharma India Ltd - 506820 - Disclosure Of Related Party Transactions

BSE India

Pursuant to the provisions of Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we enclose herewith the disclosure of Related Party Transactions for half year ended September 30, 2021 for your information and records.

pdf

AstraZeneca Pharma India Ltd.

27 Nov 2021

9027.50

2.49%

LIVE: New Covid-19 variant triggers global alarm, AstraZeneca takes stock

Business Standard

AstraZeneca said it was examining the impact of a new coronavirus variant that is spreading rapidly in South Africa on its vaccine and its antibody cocktail

AstraZeneca Pharma India Ltd. is trading above all available SMAs

AstraZeneca examining impact of new Covid-19 variant on vaccine

Business Standard | 27 Nov 2021

Is AstraZeneca Pharma India Ltd. worth buying?

148 Votes:

Buy 70.95%

Sell 19.59%

Hold 9.46%

45.14% Gain from 52W Low

AstraZeneca Pharma India Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on AstraZeneca Pharma India Ltd. from all sources in a single place.